The Potential Role of Exosomes in Child and Adolescent Obesity

Ioanna Maligianni1,2, Christos Yapijakis1,2, Flora Bacopoulou2,3

  • 1Unit of Orofacial Genetics, First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, 1 Thivon Street, Goudi, 11527 Athens, Greece.

Insights

Childhood obesity is a major public health issue. Exosomes carrying non-coding RNAs may drive obesity and related diseases, offering potential diagnostic and therapeutic targets.

Area of Science:

  • Cell Biology
  • Metabolic Disorders
  • Public Health

Background:

  • Child and adolescent obesity is a growing global health crisis.
  • Obesity is linked to chronic inflammation and increased risk of metabolic and cardiovascular diseases.
  • Exosomes, extracellular vesicles, mediate intercellular communication and are implicated in various physiological and pathological processes.

Purpose of the Study:

  • To review the role of exosomes and their non-coding RNA cargo in the development of obesity and associated metabolic and inflammatory disorders.
  • To explore the involvement of exosomal microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in adipocyte biology and gene regulation related to obesity.
  • To compare findings in children and adolescents with existing adult studies and propose mechanisms of action.

Main Methods:

  • Literature review focusing on exosomes, non-coding RNAs (miRNAs, lncRNAs), and their role in obesity.
  • Analysis of existing data on exosomal cargo in obese children and adolescents, compared to adult studies.
  • Speculation on the mechanisms by which exosomal contents influence obesity pathogenesis.

Main Results:

  • Exosomes and their ncRNA cargo (miRNAs, lncRNAs) are increasingly recognized as contributors to obesity pathogenesis.
  • Evidence suggests exosomal miRNAs and lncRNAs play roles in adipocyte function and gene regulation relevant to obesity.
  • Altered patterns of circulating exosomal miRNAs and lncRNAs are observed in obese individuals, with more data available for adults than children.

Conclusions:

  • Exosomal miRNAs and lncRNAs are potential biomarkers for early diagnosis and prevention of obesity and cardiometabolic risks.
  • Targeting exosomal cargo offers a novel therapeutic strategy for managing obesity and related conditions.
  • Further research is needed to fully elucidate the role of exosomal non-coding RNAs in pediatric obesity.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.1K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
888
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
64
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
79
Influence of Parents and Peers on Identity01:23

Influence of Parents and Peers on Identity

Adolescence is a pivotal period of identity formation, during which individuals begin to answer questions central to their sense of self, such as "Who am I?" and "Who do I hope to become?" Both parents and peers play critical roles in guiding adolescents through this complex developmental phase.
Parental Influence on Identity Development
Parents serve as primary guides and managers in an adolescent's life, offering support instrumental in decision-making and personal growth....
264
Sources of Self-Esteem I: Family Experience01:18

Sources of Self-Esteem I: Family Experience

Self-esteem, a crucial component of psychological development, is significantly shaped by familial experiences. The early parent-child relationship serves as a foundational influence on a child's self-concept, with long-lasting effects extending into adolescence and adulthood.Parental Behaviors and Early Self-Esteem FormationEmpirical studies have identified four principal parental behaviors that foster healthy self-esteem in children. These include expressions of acceptance, affection, and...
73